These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 18337154

  • 1. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM, Queisser MA, Königshoff M, Chrobak I, Preissner KT, Seeger W, Eickelberg O.
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension.
    Papakonstantinou E, Kouri FM, Karakiulakis G, Klagas I, Eickelberg O.
    Eur Respir J; 2008 Dec; 32(6):1504-12. PubMed ID: 18768572
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W, Foremny A, Domal-Kwiatkowska D, Smolik S, Tomasik A, Mazurek U, Wodniecki J.
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [Abstract] [Full Text] [Related]

  • 7. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R, Otsuka F, Nakamura K, Yamashita M, Otani H, Takeda M, Matsumoto Y, Kusano KF, Ito H, Makino H.
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [Abstract] [Full Text] [Related]

  • 8. Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Nakamura K, Shimizu J, Kataoka N, Hashimoto K, Ikeda T, Fujio H, Ohta-Ogo K, Ogawa A, Miura A, Mohri S, Nagase S, Morita H, Kusano KF, Date H, Matsubara H, Mochizuki S, Hashimoto K, Kajiya F, Ohe T.
    Int J Cardiol; 2010 Apr 01; 140(1):102-7. PubMed ID: 19073348
    [Abstract] [Full Text] [Related]

  • 9. The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2.
    Zhang S, Zou L, Yang T, Yang Y, Zhai Z, Xiao F, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):278-87. PubMed ID: 25704756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells.
    Atsuta H, Uchiyama T, Kanai H, Iso T, Tanaka T, Suga T, Maeno T, Arai M, Nagai R, Kurabayashi M.
    Int J Cardiol; 2009 Mar 06; 132(3):411-8. PubMed ID: 18471910
    [Abstract] [Full Text] [Related]

  • 13. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
    Pei L, Shan SM, Sun XY.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 01; 88(1):40-5. PubMed ID: 18346379
    [Abstract] [Full Text] [Related]

  • 14. PAI-1 is a novel component of the miR-17~92 signaling that regulates pulmonary artery smooth muscle cell phenotypes.
    Chen T, Huang JB, Dai J, Zhou Q, Raj JU, Zhou G.
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug 01; 315(2):L149-L161. PubMed ID: 29644896
    [Abstract] [Full Text] [Related]

  • 15. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
    Nordt TK, Lutzi S, Ruef J, Peter K, Klar E, Kübler W, Sobel BE, Bode C.
    Thromb Haemost; 2001 Nov 01; 86(5):1305-13. PubMed ID: 11816722
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
    Otsuka G, Stempien-Otero A, Frutkin AD, Dichek DA.
    Circ Res; 2007 May 11; 100(9):1300-7. PubMed ID: 17431190
    [Abstract] [Full Text] [Related]

  • 17. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
    Wu J, Jia J, Liu L, Yang F, Fan Y, Zhang S, Yan D, Bu R, Li G, Gao Y, Chen Y.
    J Am Soc Hypertens; 2017 Mar 11; 11(3):148-157.e1. PubMed ID: 28117274
    [Abstract] [Full Text] [Related]

  • 18. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ, Spink KG, Ren X, Afzal S, Banner KH, Wharton J.
    Respir Res; 2006 Jan 19; 7(1):9. PubMed ID: 16423283
    [Abstract] [Full Text] [Related]

  • 19. The 'PAI-1 paradox' in vascular remodeling.
    Diebold I, Kraicun D, Bonello S, Görlach A.
    Thromb Haemost; 2008 Dec 19; 100(6):984-91. PubMed ID: 19132221
    [Abstract] [Full Text] [Related]

  • 20. PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension.
    Kudryashova TV, Zaitsev SV, Jiang L, Buckley BJ, McGuckin JP, Goncharov D, Zhyvylo I, Lin D, Newcomb G, Piper B, Bogamuwa S, Saiyed A, Teos L, Pena A, Ranson M, Greenland JR, Wolters PJ, Kelso MJ, Poncz M, DeLisser HM, Cines DB, Goncharova EA, Farkas L, Stepanova V.
    Am J Physiol Lung Cell Mol Physiol; 2024 Sep 01; 327(3):L319-L326. PubMed ID: 38860847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.